Cardiol Therapeutics Inc. Equity
Cardiol Therapeutics Inc. (CRDL) had Equity of CAD 17.88 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-31
- 2025-12-31: Equity 17.88M CAD.
- 2024-12-31: Equity 24.73M CAD.
- 2023-12-31: Equity 28.25M CAD.
- 2022-12-31: Equity 52.20M CAD.
| Period end | Equity |
|---|---|
| 2025-12-31 | 17.88M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 24.73M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 28.25M CAD 40-F · filed 2026-03-31 |
| 2022-12-31 | 52.20M CAD 40-F · filed 2025-03-31 |
| 2021-12-31 | 76.24M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 13.27M CAD 20-F · filed 2024-04-01 |
| 2019-12-31 | 14.67M CAD 20-F · filed 2023-03-29 |